Clobazam Low Dose

DRUG2 trials

Sponsors

Lundbeck LLC

Conditions

EpilepsyEpilepsy, GeneralizedSeizures

Phase 2

Clobazam in Subjects With Lennox-Gastaut Syndrome

CompletedNCT00162981

Lundbeck LLCEpilepsy, Epilepsy, Generalized, Seizures

Start: 2005-10-31End: 2006-10-31Updated: 2012-02-09

Phase 3

Clobazam in Patients With Lennox-Gastaut Syndrome

CompletedNCT00518713

Lundbeck LLCEpilepsy, Epilepsy, Generalized, Seizures

Start: 2007-08-31End: 2010-04-30Updated: 2012-02-09

Related Papers

Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study.

2016-09-2810 citations

Optimizing Clobazam Treatment in Patients with Lennox-Gastaut Syndrome (LGS) (P2.039)

Neurology2016-04-05

Deconstructing Tolerance with Clobazam: Post Hoc Analyses from an Open-Label Extension Study (S14.002)

Neurology2016-04-05

Drug‐metabolism mechanism: Knowledge–based population pharmacokinetic approach for characterizing clobazam drug‐drug interactions

The Journal of Clinical Pharmacology2015-07-3017 citations

Clobazam Drug-Drug Interactions: A Mechanism-Based Characterization Using a Model-Based Approach (P4.259)

Neurology2015-04-061 citations